Brind.

Amgen is classified as biotech for legacy reasons, a classification influenced by past failures experienced in London.

1 report, 1 independent Updated Jul 22

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Amgen Biotech

Keep exploring

The entities involved

Amgen
American multinational biopharmaceutical company
- Amgen, City of Hope, and the California Community Foundation are involved in a life sciences and bioscience economic summit held in Downtown Los Angeles.Mon 12:08
- Geode Capital Management increased its stake in Amgen stock and filed the disclosure with the SEC.Mon 02:05
Biotech
Nothing else this week.

Related events

The biotech sector is experiencing a downturn due to drug failures, impacting companies like Amgen and Eli Lilly.Sep 8

Coverage

Newest first; wire copies grouped

Jul 22moneyweek.com